WEKA's AI data storage and memory capabilities will support Smartbird's dedicated AI clusters as part of a broader strategy to build a network of leading technology partners WEKA's AI data storage and memory capabilities will support Smartbird's dedicated AI clusters as part of a broader strategy to build a network of leading technology partners
4Tissue raises €7 million in Series A funding and appoints Stéphanie Dupont as CEO to advance its regenerative medicine technology and clinical development
MIRA-55 demonstrated significant pain relief comparable to Celebrex in a 21-day preclinical study of chronic inflammatory pain.
SCOTTSDALE, Ariz., Oct. 22, 2026 -- WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary flexible space solutions, today announced that it will release its third quarter 2026 financial results on November 5, 2026, after market close.
Dune launches Market Data Feeds: real-time trades from 200+ onchain venues across 12 chains, including OKX and ICE tokenized stocks. Request a demo today.
Acquisition Expands Climb’s European Platform and Deepens Strategic Vendor Relationships
Delivered Record First Quarter Operating Income, Up 28 Percent Year-Over-Year Strong Results Reflect Productivity Improvements, Mix Optimization and Benefits from Pricing Actions Realized Adjusted Operating Margin in Specialty Alloys Operations Segment of 37.7 Percent Demand Accelerating in Commercial Aerospace Supply Chain, Resulting in Increased Bookings
NEW YORK, Oct. 22, 2026 -- Teads Holding Co. (NASDAQ: TEAD), announced today that the company will release its third quarter 2026 results before the market opens on Thursday, November 5, 2026, followed by a conference call at 8:30 a.m. (Eastern Time) that same day to discuss the company’s results and business outlook.
The company’s L-Series timing devices are designed to scale between COTS and traditional space-grade solutions, offering shorter lead times at competitive price points The company’s L-Series timing devices are designed to scale between COTS and traditional space-grade solutions, offering shorter lead times at competitive price points
WOBURN, Mass., Oct. 22, 2026 -- Replimune Group, Inc. (NASDAQ: REPL), a commercial stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that it will host a conference call on Wednesday, October 28, 2026, at 8:00 a.m. ET to discuss its financial results and provide corporate update for the fiscal second quarter ended September 30, 2026.
STOUGHTON, Mass., Oct. 22, 2026 -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading biopharmaceutical company focused on improving the lives of people living with serious and often misunderstood conditions, today announced that it will report third quarter 2026 financial results before the market opens on Thursday November 5, 2026. Following the release of the financials, the Company will host a live conference call and webcast at 8:00 a.m. ET.
Approximately 22-day field program to be managed by Lonquist, with results to feed 3D gravity inversion and 2D modelling along key seismic profiles Approximately 22-day field program to be managed by Lonquist, with results to feed 3D gravity inversion and 2D modelling along key seismic profiles